C-BYOJGenescient
evolutionary genomics, selective screening, Drosophila
discoverydiscoveringsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-BYOJ
C-BYOJC-BYOJevolutionary genomics, selective screening, Drosophila
0-100 chain-logic scale · 15 dimensions · scored on public evidence
This placebo-controlled, double blind study evaluates the treatment effects of adding a multi-pathway botanical dietary supplement (ReBuilder) to the standard treatment regimens of subjects diagnosed with mild or moderate stage Alzheimer's Disease. The objective of the study is to determine if mild and moderate AD patients exhibit improved or stabilized cognitive function when this supplement is added to maximum tolerated doses of their standard treatments.
Biopharmaceuticals & Biotherapeutics Press Releases & News (Page 23) - PR.com Join Now Sign In Businesses Business Directory Products & Services Post Your Profile Press Releases Press Release Pricing Submit Press Release Press Release Distribution Recent Press Releases Become a Publishing Partner For Journalists Press Releases Businesses Products & Services Products Services Press Releases Submit Press Release ✕ Press Releases Press Release Pricing Submit Press Release Press Release Distribution Recent News Recent News News by Category News by US Region News by Country RSS News … Interest Technology Press Release Pricing Create Account Press Release Pricing Submit Press Release Press Release Distribution Recent News Recent News News by Category News by US Region News by Country Become a Publishing Partner For Journalists RSS News Feeds Business News Lifestyle News Public Interest News Technology News Recent Headlines Within Biopharmaceuticals & Biotherapeutics Press Releases RSS Get Email Alert New SensoLyte® SIRT1 Assay Kit Offers Industry’s Lon … s than three months. - February 05, 2010 - Health Decisions Biomarker Discovery Grant Deadline Extended RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010. “The last-minute surge in interest in the grant program has been overwhelming,” said Brett Burkholder, Director of Marketing & Business De … mber 17, 2009 - Genescient Corporation NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont® The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. - December 12, 2009 - Aciont Inc. RayBiotech Introduces Multiplex ELISA Detecting 200 Human Proteins RayBiotech, the Protein Array Pioneer Company, has just introduced the Quantibody® … ody Targeting of HIV-Infected Cells Functional Genetics, Inc. today announced a grant from the Bill & Melinda Gates Foundation to pursue an innovative approach for antibody-based targeting of HIV/AIDS. Under the terms of the agreement, Functional Genetics will investigate the use of TSG101 antibody targeting of HIV-infected cells... - Novembe
Long-Term Functional Side-Effects of Stimulants and Sedatives in Drosophila melanogaster | PLOS One Skip to main content Advertisement PLOS One Publish Submissions Getting Started Submission Guidelines Figures Tables Supporting Information LaTeX What We Publish Preprints Revising Your Manuscript Submit Now Calls for Papers Policies Best Practices in Research Reporting Human Subjects Research Animal Research Competing Interests Disclosure of Funding Sources Licenses and Copyright Data Availability Complementary Research Materials, Software and Code Sharing Ethical Publishing Practice Authorship … ew Process Editor Center Guidelines for Reviewers Accepted Manuscripts Comments Submit Your Manuscript Discover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time. Learn More Submit Now About Why Publish with PLOS ONE Journal Information Staff Editors Editorial Board Section Editors Advisory Groups Find and Read Articles Publishing Informati
Genescient Web Site – Genescient Corporation's Web Site Show Sidebar Log in Home Blog Contact Us About Corporate Overview Management Board of Directors Science Team History Strategic Alliances Contact Us Research 21st Century Biology Genescient’s Methuselah Flies Why Fruit Flies? From Genes to Networks Development Drug Development Competitive Advantage Services Fail-Early Drug Screens Disease Specific Research News News & Features Media Coverage Press Releases Publications Flying in the face of aging Genescient's Methuselah flies are more vigorous. “They beat up the other flies
Drug Development – Genescient Web Site Show Sidebar Log in Home Blog Contact Us About Corporate Overview Management Board of Directors Science Team History Strategic Alliances Contact Us Research 21st Century Biology Genescient’s Methuselah Flies Why Fruit Flies? From Genes to Networks Development Drug Development Competitive Advantage Services Fail-Early Drug Screens Disease Specific Research News News & Features Media Coverage Press Releases Publications Drug Development The pharmaceutical industry faces a number of severe problems; chief among them is the rapidly escalating cost
Management – Genescient Web Site Show Sidebar Log in Home Blog Contact Us About Corporate Overview Management Board of Directors Science Team History Strategic Alliances Contact Us Research 21st Century Biology Genescient’s Methuselah Flies Why Fruit Flies? From Genes to Networks Development Drug Development Competitive Advantage Services Fail-Early Drug Screens Disease Specific Research News News & Features Media Coverage Press Releases Publications Management Carlos Balarezo Chief Executive Officer Ben Goertzel, Ph.D. Chief Science Officer Cristina Rizza, M.D. Chief Medical Office
Who's Who in Gerontology: Genescient Genomics GenAge A curated database of candidate human ageing-related genes and genes associated with longevity and/or ageing in model organisms. Search human Search model organisms GenDR A curated database of genes associated with dietary restriction in model organisms either from genetic manipulation experiments or gene expression profiling. Search gene manipulations Search gene expression LongevityMap Database of human genetic variants associated with longevity. Search genes/variants CellAge Database of human genes associated with cellular senescence. Sea
Fail-Early Drug Screens – Genescient Web Site Show Sidebar Log in Home Blog Contact Us About Corporate Overview Management Board of Directors Science Team History Strategic Alliances Contact Us Research 21st Century Biology Genescient’s Methuselah Flies Why Fruit Flies? From Genes to Networks Development Drug Development Competitive Advantage Services Fail-Early Drug Screens Disease Specific Research News News & Features Media Coverage Press Releases Publications Fail-Early Drug Screens One of the most difficult problems facing pharmaceutical development is the need to discard drug